Viewing Study NCT02171520


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-03-05 @ 8:51 AM
Study NCT ID: NCT02171520
Status: COMPLETED
Last Update Posted: 2014-06-24
First Post: 2014-06-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence of Two Different Generations of Drug Product of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1160.70
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators